Top stories in gastroenterology: Highlights from Digestive Disease Week
Click Here to Manage Email Alerts
Research from the virtual Digestive Disease Week meeting dominated the top stories in gastroenterology last week. One study showed that a non-invasive blood test was able to detect early stages of colorectal cancer.
Another top story was about inappropriate use of proton pump inhibitors (PPIs), which was observed in more than one quarter of patients discharged from the ICU during a recent retrospective cohort study.
Read these and more top stories in gastroenterology below:
Non-invasive blood assay can detect early CRC
A novel, blood-based assay improved the detection of advanced and non-advanced adenomas by analyzing cell-free DNA and circulating gastrointestinal epithelial cells, according to research from Digestive Disease Week. Read more.
Complex ICU patients at higher risk for inappropriate PPIs
Among patients in the ICU without a documented indication for PPI use, more than one quarter were still discharged on a PPI, according to data from Digestive Disease Week. Read more.
No increased risk for cancer seen with ranitidine vs famotidine
Researchers found no evidence of an increased risk for various cancers among patients who used ranitidine compared with those who used famotidine; however, ranitidine users compared with the general population were more likely to have a cancer diagnosis and other risk factors for cancer. Read more.
Decreased sleep associated with constipation among U.S adults
Results from a nationwide survey showed that both decreased and increased sleep correlated with constipation among U.S. adults, with too little sleep persistently increasing risk by 30% after adjusting for other factors. Read more.
Antibiotics after colonoscopy linked with higher risk of subsequent IBS
Data show that antibiotic exposure within 14 days after a screening colonoscopy correlated with an increased chance of subsequent irritable bowel syndrome. Read more.